1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Prenatal DNA Sequencing Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share &
Forecast
4.2.1.
By Type (Genetic Diseases, Nonhereditary Diseases)
4.2.2.
By Application (Hemophilia, Down Syndrome, Cystic
Fibrosis, Autism, Others)
4.2.3.
By End user (Hospitals And Clinics, Pharmaceutical And
Biotechnology Companies, Others)
4.2.4.
By Region
4.2.5.
By Company (2022)
4.3.
Market Map
4.3.1.
By Type
4.3.2.
By Application
4.3.3.
By End user
4.3.4.
By Region
5. Asia Pacific Prenatal DNA Sequencing Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1.
By Type
5.2.2.
By Application
5.2.3.
By End user
5.2.4.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China Prenatal DNA
Sequencing Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Type
5.3.1.2.2.
By Application
5.3.1.2.3.
By End user
5.3.2.
India Prenatal DNA
Sequencing Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Type
5.3.2.2.2.
By Application
5.3.2.2.3.
By End user
5.3.3.
Australia Prenatal
DNA Sequencing Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Type
5.3.3.2.2.
By Application
5.3.3.2.3.
By End user
5.3.4.
Japan Prenatal DNA
Sequencing Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Type
5.3.4.2.2.
By Application
5.3.4.2.3.
By End user
5.3.5.
South Korea Prenatal
DNA Sequencing Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Type
5.3.5.2.2.
By Application
5.3.5.2.3.
By End user
6. Europe Prenatal DNA Sequencing Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Type
6.2.2.
By Application
6.2.3.
By End user
6.2.4.
By Country
6.3.
Europe: Country
Analysis
6.3.1.
France Prenatal DNA
Sequencing Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Application
6.3.1.2.3.
By End user
6.3.2.
Germany Prenatal DNA
Sequencing Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Application
6.3.2.2.3.
By End user
6.3.3.
Spain Prenatal DNA
Sequencing Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Application
6.3.3.2.3.
By End user
6.3.4.
Italy Prenatal DNA
Sequencing Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Type
6.3.4.2.2.
By Application
6.3.4.2.3.
By End user
6.3.5.
United Kingdom Prenatal
DNA Sequencing Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Type
6.3.5.2.2.
By Application
6.3.5.2.3.
By End user
7. North America Prenatal DNA Sequencing Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1. By Type
7.2.2.
By Application
7.2.3.
By End user
7.2.4.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States Prenatal
DNA Sequencing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Application
7.3.1.2.3.
By End user
7.3.2.
Mexico Prenatal DNA
Sequencing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Application
7.3.2.2.3.
By End user
7.3.3.
Canada Prenatal DNA
Sequencing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Application
7.3.3.2.3.
By End user
8. South America Prenatal DNA Sequencing Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1. By Type
8.2.2.
By Application
8.2.3.
By End user
8.2.4.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil Prenatal DNA
Sequencing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Application
8.3.1.2.3.
By End user
8.3.2.
Argentina Prenatal
DNA Sequencing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Application
8.3.2.2.3.
By End user
8.3.3.
Colombia Prenatal
DNA Sequencing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Application
8.3.3.2.3.
By End user
9. Middle East and Africa Prenatal DNA Sequencing Market
Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Type
9.2.2.
By Application
9.2.3.
By End user
9.2.4.
By Country
9.3.
MEA: Country
Analysis
9.3.1.
South Africa Prenatal
DNA Sequencing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By End user
9.3.2.
Saudi Arabia Prenatal
DNA Sequencing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By End user
9.3.3.
UAE Prenatal DNA
Sequencing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By End user
9.3.4.
Egypt Prenatal DNA
Sequencing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Application
9.3.4.2.3.
By End user
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends & Developments
11.1.
Recent Developments
11.2.
Application Launches
11.3.
Mergers &
Acquisitions
12.
Global Prenatal DNA
Sequencing Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Application
14.
Competitive
Landscape
14.1. Agilent Technologies Inc
14.1.1.1.
Business Overview
14.1.1.2.
Company Snapshot
14.1.1.3.
Application &
Services
14.1.1.4.
Current Capacity
Analysis
14.1.1.5.
Financials (In case
of listed)
14.1.1.6.
Recent Developments
14.1.1.7.
SWOT Analysis
14.2.
BGI Group
14.3.
F. Hoffmann-La Roche
ltd
14.4.
Illumina Inc
14.5.
Laboratory
Corporation of America Holdings
14.6.
Natera Inc
14.7.
Genomic Health Inc
14.8.
Myriad Genetics Inc
14.9.
PerkinElmer Inc
15.
Strategic Recommendations
16. About Us & Disclaimer